• Users Online: 277
  • Print this page
  • Email this page
AUTHOR REPLY
Year : 2019  |  Volume : 9  |  Issue : 2  |  Page : 136-137

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”


1 Department of Ophthalmology and Visual Science, University of Chicago, 5841 S. Maryland Avenue, MC2114, Chicago, USA
2 Retina Consultants, Ltd, 2454 E Dempster St, Suite 400, Des Plaines, IL, USA
3 Department of Ophthalmology and Visual Science, University of Chicago, 5841 S. Maryland Avenue, MC2114, Chicago; Retina Consultants, Ltd, 2454 E Dempster St, Suite 400, Des Plaines, IL, USA

Correspondence Address:
Dr. Michael P Blair
Retina Consultants, Ltd, 2454 E Dempster St, Suite 400, Des Plaines, IL, 60016
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tjo.tjo_10_19

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1594    
    Printed41    
    Emailed0    
    PDF Downloaded153    
    Comments [Add]    

Recommend this journal